In a patient with random glucose 377 mg/dL on insulin glargine (Lantus) 25 units at bedtime plus a medium‑strength sliding‑scale insulin regimen, and a morning glucose of 143 mg/dL with normal anion gap and bicarbonate, how should the insulin regimen be adjusted?

Insulin Regimen Adjustment for Improved Glycemic Control

Increase the Lantus dose by 4 units every 3 days until fasting glucose consistently reaches 80–130 mg/dL, and simultaneously add 4 units of rapid-acting insulin before the largest meal to address daytime hyperglycemia. 1

Immediate Assessment of Current Control

Your patient's glucose pattern reveals inadequate basal insulin coverage (morning glucose 143 mg/dL is acceptable, but random 377 mg/dL indicates profound daytime hyperglycemia) combined with complete absence of prandial insulin to cover meals. 1, 2 The normal anion gap and bicarbonate rule out diabetic ketoacidosis, permitting aggressive subcutaneous insulin titration rather than IV insulin. 1

Why the Current Regimen Is Failing

• Lantus 25 units at bedtime provides only partial basal coverage; the fasting glucose of 143 mg/dL suggests the basal dose is close but not optimal (target 80–130 mg/dL). 1, 3
• Medium sliding-scale insulin alone is explicitly condemned by all major diabetes guidelines because it treats hyperglycemia after it occurs rather than preventing it, leading to dangerous glucose fluctuations. 1, 2, 4
• Only ≈38% of patients achieve mean glucose <140 mg/dL with sliding-scale monotherapy versus ≈68% with scheduled basal-bolus therapy. 1, 2
• The random glucose of 377 mg/dL reflects both inadequate basal coverage AND uncontrolled postprandial excursions requiring mealtime insulin. 1

Step 1: Aggressive Basal Insulin Titration

Increase Lantus by 4 units every 3 days while fasting glucose remains ≥180 mg/dL; once fasting glucose falls to 140–179 mg/dL, switch to 2-unit increments every 3 days. 1, 3

Titration Protocol

• If fasting glucose ≥180 mg/dL: increase by 4 units every 3 days. 1
• If fasting glucose 140–179 mg/dL: increase by 2 units every 3 days. 1
• Target fasting glucose: 80–130 mg/dL. 1, 3
• If any glucose <70 mg/dL: reduce the dose by 10–20% immediately. 1

Critical Threshold Warning

Stop basal escalation when Lantus approaches 0.5 units/kg/day (roughly 35–50 units for most adults) without achieving targets; further increases lead to "over-basalization" with increased hypoglycemia risk and suboptimal control. 1 Clinical signals include:

• Basal dose >0.5 units/kg/day
• Bedtime-to-morning glucose differential ≥50 mg/dL
• Any hypoglycemia despite overall hyperglycemia
• High day-to-day glucose variability 1

Step 2: Initiate Prandial Insulin Coverage

Start with 4 units of rapid-acting insulin (lispro, aspart, or glulisine) before the largest meal (or 10% of current basal dose). 1 The random glucose of 377 mg/dL clearly indicates the need for mealtime coverage, not just basal adjustment. 1

Prandial Insulin Administration

• Timing: Administer 0–15 minutes before meals (ideally immediately before eating) for optimal postprandial control. 1
• Initial dose: 4 units before the largest meal. 1
• Titration: Increase by 1–2 units every 3 days based on 2-hour postprandial glucose readings. 1
• Target postprandial glucose: <180 mg/dL. 1

Correction Insulin Protocol (Adjunct Only)

• Add 2 units for pre-meal glucose >250 mg/dL. 1
• Add 4 units for pre-meal glucose >350 mg/dL. 1
• Correction doses must supplement—not replace—scheduled basal and prandial insulin. 1, 2

Step 3: Discontinue Sliding-Scale Monotherapy

Immediately transition from sliding-scale-only to a scheduled basal-bolus regimen. 1, 2 Sliding-scale insulin should be used only as correction doses in addition to scheduled basal and prandial insulin, never as the sole treatment. 1, 2, 4

Why This Change Is Critical

• Sliding-scale monotherapy provides no basal insulin to suppress hepatic glucose production between meals and overnight, resulting in persistent fasting hyperglycemia. 1
• It also lacks scheduled prandial insulin, causing postprandial spikes that are later corrected with large reactive doses, creating a cycle of hyperglycemia → large correction → hypoglycemia → rebound hyperglycemia. 1
• The American Diabetes Association and all major diabetes societies explicitly condemn sliding-scale insulin as a sole regimen. 1, 2

Monitoring Requirements

• Daily fasting glucose to guide basal insulin adjustments. 1
• Pre-meal glucose before each meal to calculate correction doses. 1
• 2-hour postprandial glucose after meals to assess prandial adequacy. 1
• Reassess insulin doses every 3 days during active titration. 1
• HbA1c every 3 months until stable control is achieved. 1

Expected Clinical Outcomes

• With properly implemented basal-bolus therapy, ≈68% of patients achieve mean glucose <140 mg/dL, compared with ≈38% on sliding-scale alone. 1, 2
• HbA1c reduction of 2–3% is achievable within 3–6 months with intensive insulin titration. 1
• Properly executed basal-bolus regimens do not increase hypoglycemia incidence compared with inadequate sliding-scale approaches. 1

Common Pitfalls to Avoid

• Never continue sliding-scale insulin as monotherapy when glucose repeatedly exceeds 180 mg/dL; this strategy is inferior and unsafe. 1, 2
• Do not delay adding prandial insulin when random glucose is 377 mg/dL; this clearly indicates the need for both basal and prandial coverage. 1
• Avoid increasing basal insulin beyond 0.5–1.0 units/kg/day without addressing postprandial hyperglycemia, to prevent over-basalization and hypoglycemia. 1
• Never use rapid-acting insulin at bedtime as a sole correction dose, as this markedly raises nocturnal hypoglycemia risk. 1

Hypoglycemia Management

• Treat any glucose <70 mg/dL immediately with 15 g of fast-acting carbohydrate, recheck in 15 minutes, and repeat if needed. 1
• If hypoglycemia occurs without an obvious cause, reduce the implicated insulin dose by 10–20% promptly. 1

Patient Education Essentials

• Hypoglycemia recognition and treatment: consume ≈15 g fast-acting carbohydrate when glucose <70 mg/dL, recheck in 15 minutes. 1
• Proper insulin injection technique and site rotation to prevent lipodystrophy. 1
• Self-titration algorithm empowering patients to adjust basal dose based on fasting glucose values. 1
• Sick-day guidance: continue insulin even if oral intake is limited, check glucose every 4 hours, maintain adequate hydration. 1